Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4663922
Author(s) Wolter, Angelique; Bucher, Christian H; Kurmies, Sebastian; Schreiner, Viktoria; Konietschke, Frank; Hohlbaum, Katharina; Klopfleisch, Robert; Löhning, Max; Thöne-Reineke, Christa; Buttgereit, Frank; Huwyler, Jörg; Jirkof, Paulin; Rapp, Anna E; Lang, Annemarie
Author(s) at UniBasel Huwyler, Jörg
Year 2023
Title A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models
Journal Scientific reports
Volume 13
Number 1
Pages / Article-Number 3824
Mesh terms Female; Male; Animals; Mice; Mice, Inbred C57BL; Pain Management; Buprenorphine, pharmacology; Tramadol, pharmacology; Drinking Water; Pain; Analgesia; Femoral Fractures; Agnosia; Disease Models, Animal
Abstract

Adequate pain management is essential for ethical and scientific reasons in animal experiments and should completely cover the period of expected pain without the need for frequent re-application. However, current depot formulations of Buprenorphine are only available in the USA and have limited duration of action. Recently, a new microparticulate Buprenorphine formulation (BUP-Depot) for sustained release has been developed as a potential future alternative to standard formulations available in Europe. Pharmacokinetics indicate a possible effectiveness for about 72 h. Here, we investigated whether the administration of the BUP-Depot ensures continuous and sufficient analgesia in two mouse fracture models (femoral osteotomy) and could, therefore, serve as a potent alternative to the application of Tramadol via the drinking water. Both protocols were examined for analgesic effectiveness, side effects on experimental readout, and effects on fracture healing outcomes in male and female C57BL/6N mice. The BUP-Depot provided effective analgesia for 72 h, comparable to the effectiveness of Tramadol in the drinking water. Fracture healing outcome was not different between analgesic regimes. The availability of a Buprenorphine depot formulation for rodents in Europe would be a beneficial addition for extended pain relief in mice, thereby increasing animal welfare.

ISSN/ISBN 2045-2322
Full Text on edoc
Digital Object Identifier DOI 10.1038/s41598-023-30641-9
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/36882427
   

MCSS v5.8 PRO. 0.333 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/03/2024